durvalumab
astrazeneca
['sclc', '8513', 'nsclc']
#asco22 dr. discusses abstracts #8511-8513 on immunotherapy in earlier stage nsclc. notes that we have made tremendous progress in curative-intent nsclc with recent advances changing soc. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him